12 Recruiting Head and Neck Squamous Cell Carcinoma (HNSCC) Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Head and Neck Squamous Cell Carcinoma (HNSCC) Studies
🟡 Not Yet Recruiting Early Phase1 💊 Investigational Drug / Biologic
[18F]-AraG PET Imaging in LA HNSCC
📍 Indiana University — Indianapolis, Indiana
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
📍 University of California Los Angeles — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma
📍 University of Arizona Cancer Center - North Campus — Tucson, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
📍 University of Southern California — Los Angeles, California
View Study & Checklist ➔